Bollyky & Kesselheim on U.S. Prescription Drug Importation
Thomas J. Bollyky (Council on Foreign Relations) & Aaron S. Kesselheim (Brigham and Women's Hospital/Harvard Medical School) have posted Reputation and Authority: The FDA and the Fight over U.S. Prescription Drug Importation (Vanderbilt Law Review, Vol. 73, No. 5, 1331) on SSRN. Here is the abstract:
There is popular and bipartisan support for legalizing the importation of lower-cost medicines from Canada to help reduce the high prescription drug costs that Americans pay. Despite the wide interest in this policy, attempts over the last sixteen years to create a formal system for large-scale prescription drug importation in the United States have failed. The Trump Administration recently issued a final rule to enable the legal importation of prescription drugs from Canada, but the rule has important design flaws and seems destined to suffer a similar fate as previous efforts.